Other Information
+Added: During the period from January 1, 2025 to March 31, 2025, our Chief Executive Officer adopted a contract, instructions or written plans for the sale of our securities as noted below:
+Added: Trading Arrangement
+Added: Total Shares Authorized
+Added: Name and Title
+Added: Non-Rule 10b5 -1**
+Added: to be Sold***
+Added: Chief Executive Officer and Director
+Added: _______________
+Added: Intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
+Added: Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
+Added: Represents the maximum number of shares that may be sold pursuant to the 10b5-1 trading arrangement.
+Added: The number of shares sold is dependent on the satisfaction of certain conditions as set forth in the written plan and the satisfaction of applicable vesting conditions of equity awards.
+Added: These shares would be sold through option exercises pursuant to a employee stock option grants.
+Added: In addition, our officers (as defined in Rule 16a-1(f) under the Exchange Act) have historically entered into sell-to-cover arrangements which constitute "non-Rule 10b5-1 trading arrangements" authorizing the pre-arranged sale of shares to our satisfy tax withholding obligations arising exclusively from the vesting of time-vesting or performance-vesting restricted stock units and the related issuance of shares.
+Added: The amount of shares to be sold to satisfy the our tax withholding obligations under these arrangements has been dependent on future events which cannot be known in advance, including the future trading price of our shares.
+Added: The expiration date relating to these arrangements has been dependent on future events which cannot be known in advance, including the final vest date of the applicable time-vesting or performance-vesting restricted stock units and the officer’s termination of service.
Index to Exhibits
14 unchanged sentences
April 27, 2015
−Removed: Warrant to Purchase Stock issued to Silicon Valley Bank on December 22, 2017
−Removed: March 20, 2018
−Removed: Warrant to Purchase Stock issued to Solar Capital Ltd.
−Removed: on December 22, 2017
−Removed: March 20, 2018
−Removed: aTyr Pharma, Inc.
−Removed: Non-Qualified Option Agreement for Non-Plan Inducement Grant
−Removed: August 13, 2024
+Added: 2015 Stock Option Plan and Incentive Plan, as amended
Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
12 unchanged sentences
Filed herewith
−Removed: Incorporated by Reference
−Removed: Exhibit Title
Cover Page Interactive Data File (embedded within the Inline XBRL document)
Filed herewith
+Added: * Indicates a management contract or compensatory plan, contract or arrangement.
# The information in Exhibits 32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.
1 unchanged sentence
aTyr Pharma, Inc.
−Removed: November 7, 2024
/s/ Sanjay S.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.